Matches in Wikidata for { <http://www.wikidata.org/entity/Q90359675> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90359675 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90359675 description "scientific article published on 01 June 2018" @default.
- Q90359675 description "wetenschappelijk artikel" @default.
- Q90359675 description "наукова стаття, опублікована в червні 2018" @default.
- Q90359675 name "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 name "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 type Item @default.
- Q90359675 label "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 label "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 prefLabel "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 prefLabel "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 P1433 Q90359675-832FD21D-E0E6-40CD-ADA2-7353ACD289E4 @default.
- Q90359675 P1476 Q90359675-65D47B75-9DA9-4E46-A414-49D40C7500AB @default.
- Q90359675 P2093 Q90359675-5E8B684D-50F3-420C-BD85-EFCF896D7AE2 @default.
- Q90359675 P2093 Q90359675-DD7D29BD-3576-42CD-AEB9-E065BC54CEFF @default.
- Q90359675 P2093 Q90359675-E785C236-BE18-4C92-AFDB-2060961311FE @default.
- Q90359675 P304 Q90359675-8A11E00D-37D5-4193-B70F-4A532A9CA40C @default.
- Q90359675 P31 Q90359675-C55749BC-4CC0-4B51-97B2-0EFA710D7514 @default.
- Q90359675 P356 Q90359675-500F1405-7D54-49B4-972F-1A6D2B055828 @default.
- Q90359675 P478 Q90359675-84C28D34-7F76-4269-9C2C-3F7CCBA5C97A @default.
- Q90359675 P577 Q90359675-F008DC08-5C51-494F-9ECA-17A737D011A4 @default.
- Q90359675 P921 Q90359675-1B9F9F65-AD99-441D-9C73-AE474E9D9751 @default.
- Q90359675 P921 Q90359675-A67A3BA4-053C-41A3-9A94-AA4D0B6AD2BE @default.
- Q90359675 P921 Q90359675-C7F38976-1B22-4B0D-938F-232B2D304316 @default.
- Q90359675 P921 Q90359675-CB01D11B-6170-40E0-906E-E8A6C3486EEA @default.
- Q90359675 P921 Q90359675-FEBE2517-BDDB-4A58-B986-DD7B14F4D27C @default.
- Q90359675 P356 MDY151.273 @default.
- Q90359675 P1433 Q326122 @default.
- Q90359675 P1476 "The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)" @default.
- Q90359675 P2093 "A Mochalova" @default.
- Q90359675 P2093 "E Ledin" @default.
- Q90359675 P2093 "Y Zaitseva" @default.
- Q90359675 P304 "v77" @default.
- Q90359675 P31 Q13442814 @default.
- Q90359675 P356 "10.1093/ANNONC/MDY151.273" @default.
- Q90359675 P478 "29 Suppl 5" @default.
- Q90359675 P577 "2018-06-01T00:00:00Z" @default.
- Q90359675 P921 Q108566365 @default.
- Q90359675 P921 Q188874 @default.
- Q90359675 P921 Q238512 @default.
- Q90359675 P921 Q412197 @default.
- Q90359675 P921 Q422327 @default.